-
CTN 343: Project ReportNeedles.ca
Project ReportNeedles.ca: A rapid assessment and response system to map needle prevalence and implement harm reduction interventions in Regina, Saskatchewan
-
CTN 338: PLATINUM-CAN
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
-
-
CTNPT 050: Perception of menopausal hormone therapy among women living with HIV
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
-
CTNPT 043: Endocannabinoid system and inflamm-aging in HIV-associated atherosclerosis
Interplay between expanded endocannabinoid (eCB) system and inflamm-aging: Implication for accelerated atherosclerosis in people living with HIV (PLWH) under ART
-
CTNPT 047: Letermovir in ART-treated HIV-infected persons
Influence of a 3-month letermovir treatment on gut inflammation in ART-treated HIV-infected persons in an open labelled controlled randomized study
-
CTN 331: DDI Study: Drug-drug interactions between ART and feminizing hormones in trans women living with HIV
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
-
CTN 327: Impact of COVID-19 on persons with HIV in Canada
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
-
CTN 272: Canadian HIV and Aging cohort
Determinants of Increased Risk of Cardiovascular Diseases in Individuals Living with HIV
-
CTN 236: HPV vaccine in HIV positive girls and women
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
-
CTN 293: REPRIEVE trial
Randomized Trial to Prevent Vascular Events in HIV REPRIEVE is the first large-scale randomized clinical research trial to test a strategy for heart disease prevention among people living with HIV. Specifically, REPRIEVE will test whether a daily dose of a statin (pitavastatin) reduces the risk of heart disease among people living with HIV.
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More